Celeste A. Boeckman

Celeste Boeckman practices at Oklahoma Kidney Care in Oklahoma City, Oklahoma.

Celeste Boeckman's NPI, 1083903728, was assigned on April 4, 2011. Celeste Boeckman holds Oklahoma license 5186.

Celeste Boeckman's primary practice is Oklahoma Kidney Care, at 13901 McAuley Blvd, Oklahoma City, OK 73134 in Oklahoma County. The practice phone is (405) 748-5800.

Celeste Boeckman's primary practice is Oklahoma Kidney Care in Oklahoma City, Oklahoma. Celeste Boeckman is also affiliated with Mercy Hospital Oklahoma City. The medical group on file is Oklahoma Kidney Care. Dmand AI also links Celeste Boeckman to 4 more hospitals, 5 dialysis centers, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Celeste Boeckman practices, 12 sites in all. Vendor and product names are available with a free account.

Nephrology is Celeste Boeckman's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Celeste Boeckman is licensed in Oklahoma.

CMS data shows 2,396 Medicare services from Celeste Boeckman across 12 procedure codes in 2024, for 597 Medicare patients. Medicare paid $186,872 for them.

CMS counts 597 Medicare patients who saw Celeste Boeckman in 2024. The largest group is 75 to 84, with 248 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 9% are also on Medicaid. Their average risk score is 3.40, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Celeste Boeckman's median patient age at 72, with 52% women.

In 2024, Celeste Boeckman wrote 1,854 Medicare Part D claims for 364 patients. 75% of them were for generic drugs. CMS names the drug for 1,661 of them, across 25 drugs with 11 or more claims each, at $413,973 in total drug cost. In 2023, CMS named 938 claims across 20 drugs.

Celeste Boeckman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Celeste Boeckman as offering telehealth.

CMS Open Payments shows 324 general payments to Celeste Boeckman from 32 drug and device companies from 2017 to 2025. Speaker and faculty fees make up the largest share, 93% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $59,449.